Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your child is between 4 and 12 years old and has been diagnosed with asthma by a doctor.
- Your child is already being seen regularly for their asthma by a paediatrician or lung specialist for children.
- Your child's asthma falls into a moderate or more serious category, according to international asthma guidelines (GINA grades 2, 3, or 4 — confirm with trial site if unsure which grade applies to your child).
- Your child uses pressurised inhaler devices (the standard type of inhaler that releases a puff of medicine) for both their regular and relief asthma medicines.
- Your child is covered by social security (French health insurance).
- A parent or legal guardian has agreed in writing to take part in the study alongside their child.
- There is a compatible smartphone available in the household that can download the study app.
- The parent or guardian is able, in the investigator's opinion, to understand how to use the study app and the special digital inhalers provided.
Who may not be able to join:
- Children who have another health condition that could affect the study results, such as certain lung conditions like bronchopulmonary dysplasia or cystic fibrosis (confirm with trial site for other conditions).
- Children whose parent or legal guardian is not able, in the investigator's opinion, to understand the purpose of the study or to give their consent.
- Children who receive State Medical Aid (Aide Médicale d'État) as their health coverage.
- Children who did not use the study inhaler system within 15 days of joining the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David DUMMOND, MD, PhD, Hôpital Necker Enfants Malades AP-HP
Phone: 01 87 89 20 28
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in asthma severity measured by the Composite Asthma Severity Index (CASI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.